In an individual with GVHD, miR-204 specifically targeted IL-6R, inhibiting the IL-6/IL-6R/Stat3 pathway and encouraging the transformation of inflammatory M1 macrophages into the immunosuppressive M2 phenotype. The gene discussed is IL6R; the disease is graft versus host disease.